The Differences in INA-CBG's Claims and Direct Medical Costs for Inpatient Breast Cancer in Class A and B Hospital IN PRESS
Abstract
With a total cost of 3.5 trillion rupiahs, cancer ranks second due to its high price and potential for life-threatening complications. The purpose of this study is to ascertain whether real costs in Indonesian Hospital Types A and B that use INA-CBG rates for JKN patients are appropriate given INA-CBG code C-3-13-0. Methods: A cross-sectional research approach was used in this observational study. By looking up medication information, cost information, and medical record documents for outpatient cancer patients at Type A and B hospitals for 2021, data was obtained retroactively. The Mann-Whitney test was employed in statistical analysis to determine the discrepancy between INA-CBG's rates and actual expenditures. Findings: PBI outpatient breast cancer patients at Type A Hospital had average direct medical costs of IDR 3,397,073, non-PBI patients IDR 3,439,253, and medical cost components IDR 2,619,355.26 at Type B Hospital. Drug bills are the largest direct contributor. The true costs in Type A hospitals for PBI patients are less than Rp 88,041,600; for non-PBI patients, the difference is minus Rp 91,386,300; and for patients in Type B hospitals, the difference is minus Rp 164,113,635. Conclusion: For patients with outpatient breast cancer at Type A and B hospitals, there is a considerable discrepancy between the true expenses and the total INA-CBG rates (p = 0.0001).
Full text article
Authors
Authors who publish with Jurnal Ilmu Kesehatan Masyarakat (JIKM) agree to the following conditions:
- The author retains the copyright and gives the editorial board the first right to be published with work that is simultaneously licensed under the Creative Commons Linking License that allows others to share (copy and redistribute) material in the media or format an adaptation of the work for any purpose.
- Authors can enter into separate additional contractual arrangements for the non-exclusive distribution of published journal works (for example, posting them to institutional repositories or publishing them in books), with recognition of the initial publication of this journal.